Genotyping
About:
Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology.
Website: http://genotyping.com.br/
Twitter/X: genotyping_sp
Top Investors: SP Ventures
Description:
Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology. Genotyping is a Brazilian biotechnology company founded in 2008 by UNESP researchers together with entrepreneurs. In 2013, the company expanded its operations to the molecular diagnostics industry, pioneering the next-generation sequencing to use for genetic analysis. Located in Botucatu, it has a modern laboratory with operating license that is FDA approved, has qualified and personalized customer service. The company has scientific and technical body able to perform a full range of molecular analysis of the human genome, enabling the development of new tests to meet specific customer needs. The company provides genetic panels that assess multiple genes in a single analysis, enabling physicians to offer patients the latest diagnosis associated with prevention.
4M BRL
Less than $1M
Botucatu, Sao Paulo, Brazil
2008-01-01
contato(AT)genotyping.com.br
1-10
2015-09-03
Private
© 2025 bioDAO.ai